JP2007519622A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007519622A5 JP2007519622A5 JP2006544171A JP2006544171A JP2007519622A5 JP 2007519622 A5 JP2007519622 A5 JP 2007519622A5 JP 2006544171 A JP2006544171 A JP 2006544171A JP 2006544171 A JP2006544171 A JP 2006544171A JP 2007519622 A5 JP2007519622 A5 JP 2007519622A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- composition according
- divalent cation
- antimicrobial composition
- molar ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 13
- 230000000845 anti-microbial Effects 0.000 claims 7
- 150000001768 cations Chemical class 0.000 claims 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 230000000844 anti-bacterial Effects 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 208000003251 Pruritus Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000008838 periodontal disease Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Claims (12)
- 前記ペプチドが、約70個未満のアミノ酸である、請求項1に記載の抗菌性組成物。
- 前記二価陽イオンが、Zn2+、Ca2+、Cu2+、Ni2+、Co2+、Fe2+、Sn2+、Mn2+、SnF+およびCuF+を含む群から選択される、請求項1から4のいずれか一項に記載の抗菌性組成物。
- 前記二価陽イオンがCa2+またはZn2+である、請求項5に記載の抗菌性組成物。
- 前記組成物における、前記二価陽イオンの前記ペプチドに対するモル比が0.5から15.0:1.0の範囲である、請求項1から6のいずれか一項に記載の抗菌性組成物。
- 前記二価陽イオンの前記ペプチドに対する前記モル比が0.5:1.0から4.0:1.0の範囲である、請求項7に記載の抗菌性組成物。
- 前記二価陽イオンの前記ペプチドに対する前記モル比が1.0:1.0から4.0:1.0の範囲である、請求項8に記載の抗菌性組成物。
- 前記二価陽イオンの前記ペプチドに対する前記モル比が1.0:1.0から2.0:1.0の範囲である、請求項9に記載の抗菌性組成物。
- 請求項1から10のいずれか一項に記載の組成物および製薬上許容できる担体を含む医薬組成物。
- 被験者の齲触または歯周病を治療または予防するための医薬の調製における、請求項1から11のいずれか一項に記載の組成物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003907002 | 2003-12-19 | ||
AU2003907002A AU2003907002A0 (en) | 2003-12-19 | Antimicrobial composition | |
PCT/AU2004/001764 WO2005058344A1 (en) | 2003-12-19 | 2004-12-15 | Antimicrobial composition |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007519622A JP2007519622A (ja) | 2007-07-19 |
JP2007519622A5 true JP2007519622A5 (ja) | 2007-11-01 |
JP4847341B2 JP4847341B2 (ja) | 2011-12-28 |
Family
ID=34682623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006544171A Expired - Fee Related JP4847341B2 (ja) | 2003-12-19 | 2004-12-15 | 抗菌性組成物 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8106152B2 (ja) |
EP (1) | EP1708735A4 (ja) |
JP (1) | JP4847341B2 (ja) |
KR (1) | KR20070026372A (ja) |
AU (2) | AU2004298285B2 (ja) |
CA (1) | CA2550581C (ja) |
MX (1) | MXPA06007043A (ja) |
NZ (1) | NZ548218A (ja) |
WO (1) | WO2005058344A1 (ja) |
ZA (1) | ZA200605660B (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10331202A1 (de) | 2003-07-10 | 2005-03-31 | S.K. Enterprise Gmbh | Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms |
DE102006036285A1 (de) * | 2006-08-03 | 2008-02-07 | "S.U.K." Beteiligungs Gmbh | Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms |
CA2735171C (en) | 2008-08-29 | 2023-10-03 | Oral Health Australia Pty Ltd | Prevention, treatment and diagnosis of p.gingivalis infection |
AU2010262763A1 (en) * | 2009-06-19 | 2012-01-19 | Oral Health Australia Pty Ltd | Casein derived protease inhibitory peptides |
AU2010317661A1 (en) * | 2009-11-11 | 2012-05-31 | Oral Health Australia Pty Ltd | Antibiofilm glycopeptides |
WO2013109927A2 (en) * | 2012-01-18 | 2013-07-25 | Metallopharm Llc | Metallodrugs having improved pharmacological properties and methods of manufacture and use thereof |
TWI782199B (zh) * | 2019-03-29 | 2022-11-01 | 高雄醫學大學 | 抗菌膠體、其製造方法及包含此抗菌膠體之系統 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH671879A5 (ja) | 1987-02-26 | 1989-10-13 | Nestle Sa | |
ES2084150T3 (es) | 1989-12-22 | 1996-05-01 | Commw Scient Ind Res Org | Aminoacidos, peptidos o sus derivados asociados a las grasas. |
US5583198A (en) | 1989-12-22 | 1996-12-10 | Commonwealth Scientific And Industrial Research Organization | Amino acids, peptides or derivatives thereof coupled to fats |
FR2686085B1 (fr) | 1992-01-10 | 1995-08-04 | Agronomique Inst Nat Rech | Peptides representant des fragments du cmp, anticorps diriges contre lesdits peptides, et leurs utilisations. |
US6096870A (en) | 1994-01-05 | 2000-08-01 | Sepragen Corporation | Sequential separation of whey |
JP3159863B2 (ja) | 1994-03-18 | 2001-04-23 | 石塚硝子株式会社 | 抗菌性を有する溶解性ガラス組成物 |
JPH07278013A (ja) | 1994-03-31 | 1995-10-24 | Snow Brand Milk Prod Co Ltd | エンドトキシン中和剤 |
GB9409387D0 (en) | 1994-05-11 | 1994-06-29 | Unilever Plc | Glucan-binding domains (gbp's) and hybird proteins containing gbd's as novel active systems targeted to dental plaque |
ZA962939B (en) * | 1995-04-12 | 1997-10-13 | Quest Int | Oral care compositions. |
EP0737470A1 (en) | 1995-04-12 | 1996-10-16 | Quest International B.V. | Oral care compositions |
AUPO566297A0 (en) | 1997-03-13 | 1997-04-10 | University Of Melbourne, The | Calcium phosphopeptide complexes |
JPH10114812A (ja) | 1997-08-22 | 1998-05-06 | Bridgestone Corp | 抗菌性軟質ポリウレタンフォームの製造方法 |
AUPP051497A0 (en) * | 1997-11-24 | 1997-12-18 | University Of Melbourne, The | Antimicrobial peptides |
AUPP494798A0 (en) | 1998-07-29 | 1998-08-20 | Pacific Biolink Pty Limited | Protective protein formulation |
US6596298B2 (en) * | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
JP2000254988A (ja) * | 1999-03-06 | 2000-09-19 | Kawakami Sangyo Kk | 焼却処理に適する気泡シート |
WO2000072685A1 (fr) | 1999-05-31 | 2000-12-07 | Houzawa, Hiromi | Procede de production d'un bactericide |
JP2001233720A (ja) * | 2000-02-24 | 2001-08-28 | Kuriinton:Kk | 殺菌性付与剤、殺菌性付与方法および殺菌袋 |
AUPR517701A0 (en) | 2001-05-21 | 2001-06-14 | University Of Melbourne, The | Dental restorative materials |
-
2004
- 2004-12-15 AU AU2004298285A patent/AU2004298285B2/en not_active Ceased
- 2004-12-15 JP JP2006544171A patent/JP4847341B2/ja not_active Expired - Fee Related
- 2004-12-15 ZA ZA200605660A patent/ZA200605660B/en unknown
- 2004-12-15 EP EP04802066A patent/EP1708735A4/en not_active Withdrawn
- 2004-12-15 MX MXPA06007043A patent/MXPA06007043A/es not_active Application Discontinuation
- 2004-12-15 NZ NZ548218A patent/NZ548218A/en not_active IP Right Cessation
- 2004-12-15 US US10/596,623 patent/US8106152B2/en not_active Expired - Fee Related
- 2004-12-15 WO PCT/AU2004/001764 patent/WO2005058344A1/en active Application Filing
- 2004-12-15 CA CA2550581A patent/CA2550581C/en not_active Expired - Fee Related
- 2004-12-15 KR KR1020067014496A patent/KR20070026372A/ko not_active Application Discontinuation
-
2010
- 2010-09-24 AU AU2010224414A patent/AU2010224414B2/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2021100937A5 (ja) | ||
JP2004534850A5 (ja) | ||
JP2021063088A5 (ja) | ||
RU2005126412A (ru) | Сор1 для лечения воспалительных заболеваний кишечника | |
RU2004110726A (ru) | Применение оксинтомодулина, способ и фармацевтическая композиция для профилактики или лечения избыточной массы тела, способ снижения массы тела | |
EP1658849A3 (en) | therapeutic combinations of antihypertensive and antiangiogenic agents | |
WO2005067898A3 (en) | Improved sustained release compositions for pulmonary administration of insulin | |
JP2007537301A5 (ja) | ||
MX2009003557A (es) | Composicion estanosa para el cuidado bucal. | |
JP2007519622A5 (ja) | ||
JP2009533356A5 (ja) | ||
JP2003508416A (ja) | 金属含有組成物、その製法および用法 | |
JP2012530073A5 (ja) | ||
JP2004519493A5 (ja) | ||
JP2005506300A5 (ja) | ||
CN101801334B (zh) | 口腔用组合物以及提高口腔用组合物的收敛性的方法 | |
JP2010513327A5 (ja) | ||
JPS6310128B2 (ja) | ||
JP2002539827A5 (ja) | ||
JP2008534537A5 (ja) | ||
JP2013510799A5 (ja) | ||
CN101125970A (zh) | 一种抗菌涂层 | |
US20040247696A1 (en) | Methods of using electron active compounds for managing conditions afflicting mammals | |
WO2006079910A3 (en) | 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity | |
US11278566B2 (en) | Agent for use for inflammatory conditions of mucous membranes |